P
|
| Pacerone |
|
 |
| See also Amiodarone |
|
 |
| prescribing information for AF (Table) |
|
 |
|
| PAD (peripheral arterial disease) |
|
 |
| Peripheral Arterial Disease section |
|
 |
| evaluation of |
|
 |
| management of (Table) |
|
 |
|
| Pagaptanib (Macugen) |
|
 |
|
| Pain |
|
 |
| Pain chapter |
|
 |
| acute |
|
 |
| definition of |
|
 |
| management of |
|
 |
| adjuvant drugs for (Table) |
|
 |
| arthritic |
|
 |
| APAP and NSAIDs for (Table) |
|
 |
| pharmacologic intervention for |
|
 |
| pharmacologic management of (Figure) |
|
 |
| assessment (Figure) |
|
 |
| back |
|
 |
| bowel obstruction |
|
 |
| carpal tunnel syndrome |
|
 |
| chronic |
|
 |
| definition of |
|
 |
| management of |
|
 |
| differential diagnosis |
|
 |
| at end of life |
|
 |
| foot |
|
 |
| heel |
|
 |
| hip |
|
 |
| in intercourse |
|
 |
| joint (Table) |
|
 |
| medications for osteoporosis and (Table) |
|
 |
| metastatic bone |
|
 |
| muscle (Table) |
|
 |
| neuropathic |
|
 |
| adjuvant drugs for (Table) |
|
 |
| examples and treatment of (Table) |
|
 |
| pharmacologic treatment of |
|
 |
| nociceptive (Table) |
|
 |
| nonrheumatic |
|
 |
| opioids for (Table) |
|
 |
| persistent |
|
 |
| definition of |
|
 |
| management of |
|
 |
| resources for |
|
 |
| shoulder |
|
 |
| types, examples, and treatment of (Table) |
|
 |
|
| Pain crisis |
|
 |
|
| Painful neuropathy |
|
 |
| examples and treatment of (Table) |
|
 |
| pain relief (Table) |
|
 |
| peripheral |
|
 |
| treatment of |
|
 |
|
| Paliperidone (Invega) (Table) |
|
 |
|
| Palliative care |
|
 |
| Palliative and End-of-Life Care chapter |
|
 |
| resources for |
|
 |
| Palliative Performance Scale, version 2 (PPSv2) |
|
 |
|
| Pallidotomy |
|
 |
|
| Pamelor |
|
 |
| See also Nortriptyline |
|
 |
| prescribing information for depression (Table) |
|
 |
| prescribing information for painful neuropathy |
|
 |
|
| Pamidronate |
|
 |
|
| Pancreatic cancer |
|
 |
|
| Pancytopenia |
|
 |
|
| Panic attack |
|
 |
|
| Panic disorder |
|
 |
| antidepressants approved for |
|
 |
| benzodiazepine management of |
|
 |
| differential diagnosis |
|
 |
| nonpharmacologic management of |
|
 |
|
| Pantoprazole (Protonix) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for GERD (Table) |
|
 |
|
| Pao2 (partial pressure of oxygen, arterial) |
|
 |
|
| Pap smear |
|
 |
| for prevention |
|
 |
| recommendations (Table) |
|
 |
|
| Paranoid (delusional) disorder, late-life |
|
 |
|
| Parasomnias |
|
 |
|
| Paraspinal exercises |
|
 |
|
| Parenteral nutrition |
|
 |
| for malnutrition |
|
 |
| solutions (Table) |
|
 |
|
| Parkinsonism |
|
 |
| classification of (Table) |
|
 |
| drug-induced |
|
 |
| distinguishing early Parkinson's disease from other parkinsonian syndromes (Table) |
|
 |
| management of (Table) |
|
 |
| vascular (Table) |
|
 |
|
| Parkinson's disease |
|
 |
| Parkinson's Disease section |
|
 |
| classification of (Table) |
|
 |
| dementia associated with |
|
 |
| differential diagnosis |
|
 |
| distinguishing early Parkinson's disease from other parkinsonian syndromes (Table) |
|
 |
| and falls (Table) |
|
 |
| medications for (Table) |
|
 |
| resources for |
|
 |
|
| Parlodel (bromocriptine) (Table) |
|
 |
|
| Paroxetine (Paxil, Paxil CR) |
|
 |
| for anxiety disorders |
|
 |
| dextromethorphan interactions (Table) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for depression (Table) |
|
 |
| prescribing information for menopausal symptoms |
|
 |
|
| Partial pressure of oxygen, arterial (Pao2) |
|
 |
|
| Paste bandages |
|
 |
|
| Patanol (olopatadine) (Table) |
|
 |
|
| Pathocil |
|
 |
| See also Dicloxacillin |
|
 |
| prescribing information for infectious diseases (Table) |
|
 |
|
| Patient-controlled analgesia (PCA) |
|
 |
| for acute pain and short-term management |
|
 |
| initial dosing (Table) |
|
 |
|
| Paxil |
|
 |
| See also Paroxetine |
|
 |
| prescribing information for depression (Table) |
|
 |
| prescribing information for menopausal symptoms |
|
 |
|
| Paxil CR |
|
 |
| See also Paroxetine |
|
 |
| prescribing information for depression (Table) |
|
 |
|
| PCA (patient-controlled analgesia) |
|
 |
| for acute pain and short-term management |
|
 |
| initial dosing (Table) |
|
 |
|
| PDE5 inhibitors |
|
 |
| prescribing information for male sexual dysfunction (Table) |
|
 |
| for SSRI-induced sexual dysfunction |
|
 |
|
| PE (pulmonary embolism) |
|
 |
| Pulmonary Embolism section |
|
 |
| anticoagulation for (Table) |
|
 |
| anticoagulation in absence of active bleeding or severe bleeding risk (Table) |
|
 |
| clinical decision rule for (Table) |
|
 |
| evaluation of suspected PE (Figure) |
|
 |
| medications for osteoporosis and (Table) |
|
 |
| prophylaxis and treatment |
|
 |
|
| Peak flow meters |
|
 |
|
| Pedal pulse |
|
 |
|
| Pediapred (prednisolone) (Table) |
|
 |
|
| Pelvic muscle (Kegel's) exercises |
|
 |
| for urge and stress UI |
|
 |
| for vaginal prolapse |
|
 |
|
| Pemirolast (Alamast) (Table) |
|
 |
|
| Penbutolol (Levatol) (Table) |
|
 |
|
| Penicillin G (Table) |
|
 |
|
| Penicillin VK (Table) |
|
 |
|
| Penicillinase-resistant penicillins (Table) |
|
 |
|
| Penicillins |
|
 |
| for cellulitis |
|
 |
| for erysipelas |
|
 |
| for folliculitis |
|
 |
| prescribing information for impetigo |
|
 |
| prescribing information for infectious diseases (Table) |
|
 |
|
| Penile prosthesis (Table) |
|
 |
|
| Penile-to-brachial pressure index |
|
 |
|
| Penlac |
|
 |
| See also Ciclopirox |
|
 |
| prescribing information (Table) |
|
 |
|
| Pentazocine |
|
 |
|
| Pentoxifylline (Trental) |
|
 |
|
| Pepcid (famotidine) (Table) |
|
 |
|
| Peptic ulcer disease |
|
 |
|
| Pepto-Bismol (bismuth subsalicylate) |
|
 |
| prescribing information for diarrhea (Table) |
|
 |
| prescribing information for H pylori-induced ulcerations (Table) |
|
 |
| prescribing information for peptic ulcer disease |
|
 |
|
| Percocet (oxycodone with APAP) (Table) |
|
 |
|
| Percodan (oxycodone with ASA) (Table) |
|
 |
|
| Percutaneous transluminal coronary angioplasty (PTCA) |
|
 |
|
| Percutaneous venting gastrostomy |
|
 |
|
| Perennial rhinitis |
|
 |
|
| Perindopril (Aceon) |
|
 |
| prescribing information for HTN (Table) |
|
 |
| target dose in HF (Table) |
|
 |
|
| Periodic limb movement disorder |
|
 |
|
| Perioperative management |
|
 |
|
| Peripheral arterial disease (PAD) |
|
 |
| Peripheral Arterial Disease section |
|
 |
| evaluation of |
|
 |
| management of (Table) |
|
 |
|
| Peripheral neuropathy |
|
 |
| Peripheral Neuropathy section |
|
 |
| pain relief (Table) |
|
 |
|
| Peripheral parenteral nutrition |
|
 |
|
| Peritoneal dialysis |
|
 |
|
| Permethrin (Elimite) |
|
 |
|
| Perphenazine (Table) |
|
 |
|
| Persantine |
|
 |
| See also Dipyridamole |
|
 |
| for stroke prevention |
|
 |
|
| Personal pocket devices |
|
 |
|
| Personality disorder |
|
 |
|
| Pertussis (Table) |
|
 |
|
| Pessaries |
|
 |
| for UI |
|
 |
| for vaginal prolapse |
|
 |
|
| Pet therapy |
|
 |
|
| Petroleum-based nonadherent dressing (Table) |
|
 |
|
| Peyronie's disease |
|
 |
|
| Pharmacodynamics (Table) |
|
 |
|
| Pharmacokinetics (Table) |
|
 |
|
| Pharmacotherapy |
|
 |
| Prescribing, Interactions chapter |
|
 |
| CMS guidance on drugs in nursing homes |
|
 |
| criteria for drugs of choice |
|
 |
| drug-drug interactions |
|
 |
| enteral nutrition interactions |
|
 |
| fall risks |
|
 |
| food interactions |
|
 |
| Medicare Part D prescription drug plan |
|
 |
| metabolic interactions (Table) |
|
 |
| nutrient interactions |
|
 |
| preventing falls with (Table) |
|
 |
| systemic medications with ocular adverse events |
|
 |
|
| Phenobarbital (Luminal) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for seizures (Table) |
|
 |
|
| Phenol |
|
 |
| camphor and phenol (Campho-Phenique) (Table) |
|
 |
| camphor-menthol-phenol (Sarna) (Table) |
|
 |
|
| Phenothiazines |
|
 |
|
| Phenylephrine + chlorpheniramine + hydrocodone (Histussin HC) (Table) |
|
 |
|
| Phenytoin (Dilantin) |
|
 |
| drug interactions (Table) |
|
 |
| drug interactions, dangerous |
|
 |
| enteral nutrition interactions |
|
 |
| food or nutrient interactions |
|
 |
| metabolic interactions (Table) |
|
 |
| monitoring (Table) |
|
 |
| and osteoporosis |
|
 |
| prescribing information for seizures (Table) |
|
 |
| and sleep problems |
|
 |
|
| Phlebotomy |
|
 |
|
| Phobia, social |
|
 |
|
| PhosLo (calcium acetate) |
|
 |
|
| Phospholine (echothiophate) (Table) |
|
 |
|
| Photodynamic therapy |
|
 |
| for AMD |
|
 |
| for basal cell carcinoma |
|
 |
|
| Physical abuse (Table) |
|
 |
|
| Physical restraints |
|
 |
|
| Physical self-maintenance scale |
|
 |
|
| Physical therapy (PT) |
|
 |
| for balance and strength training (Table) |
|
 |
| for bicipital tendinitis |
|
 |
| for dizziness (Table) |
|
 |
| for falls prevention |
|
 |
| for frozen shoulder (adhesive capsulitis) |
|
 |
| for osteoarthritis |
|
 |
| for pain management |
|
 |
| for persistent pain (Table) |
|
 |
| for preventing falls (Table) |
|
 |
| for rheumatoid arthritis |
|
 |
| for rotator cuff tears |
|
 |
| for rotator cuff tendinitis, subacromial bursitis, or rotator tendon impingement on clavicle |
|
 |
| for UI |
|
 |
|
| Physiologic tremor (Table) |
|
 |
|
| Physostigmine (Eserine, Fisostin, Isopto Eserine) (Table) |
|
 |
|
| Pilagan (pilocarpine) (Table) |
|
 |
|
| Pilocar (pilocarpine) (Table) |
|
 |
|
| Pilocarpine (Adsorbocarpine, Akarpine, Isopto Carpine, Pilagan, Pilocar, Piloptic, Pilostat) (Table) |
|
 |
|
| Pilocarpine gel (Ocusert, Pilopine HS) (Table) |
|
 |
|
| Pilopine HS (pilocarpine gel) (Table) |
|
 |
|
| Piloptic (pilocarpine) (Table) |
|
 |
|
| Pilostat (pilocarpine) (Table) |
|
 |
|
| Pindolol (Visken) (Table) |
|
 |
|
| Pioglitazone (Actos) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| with metformin (ACTOplus met) (Table) |
|
 |
| prescribing information for diabetes mellitus (Table) |
|
 |
|
| Piperacillin (Pipracil) |
|
 |
| for community-acquired pneumonia (Table) |
|
 |
| prescribing information for infectious diseases (Table) |
|
 |
|
| Piperacillin-tazobactam (Zosyn) |
|
 |
| for community-acquired pneumonia (Table) |
|
 |
| for nursing-home or hospital-acquired pneumonia |
|
 |
| prescribing information for infectious diseases (Table) |
|
 |
|
| Pipracil |
|
 |
| See also Piperacillin |
|
 |
| prescribing information for infectious diseases (Table) |
|
 |
|
| Pirbuterol (Maxair) (Table) |
|
 |
|
| Piroxicam (Feldene) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for arthritis (Table) |
|
 |
| warfarin interactions |
|
 |
|
| Pityrosporum orbiculare |
|
 |
|
| Plain NuGauze |
|
 |
| See also Gauze packing |
|
 |
| prescribing information for pressure ulcers (Table) |
|
 |
|
| Plantar fasciitis |
|
 |
|
| Platelet-derived growth factors |
|
 |
|
| Plavix (clopidogrel) |
|
 |
| for acute MI |
|
 |
| prescribing information for acute coronary syndrome (Table) |
|
 |
| prescribing information for PAD |
|
 |
| prescribing information for stroke prevention |
|
 |
|
| Plenaxis (abarelix) (Table) |
|
 |
|
| Plendil |
|
 |
| See also Felodipine |
|
 |
| prescribing information for HTN (Table) |
|
 |
|
|